Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Balance Sheets

v3.5.0.2
Interim Consolidated Balance Sheets - USD ($)
May 31, 2016
Nov. 30, 2015
CURRENT    
Cash and cash equivalent $ 1,014,166 $ 1,851,021
Accounts Receivable 22,257 39,676
Inventory 13,258 44,319
Deferred financing costs 63,741 63,741
Prepaid expenses and other receivables 33,947 27,283
Total Current Assets 1,147,369 2,026,040
Deferred financing costs 11,497 43,367
Property and Equipment 73,753 97,011
TOTAL ASSETS 1,232,619 2,166,418
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 99,386 173,329
Total Current Liabilities 99,386 173,329
Convertible Debentures 1,398,592 1,398,592
Total Liabilities 1,497,978 1,571,921
Capital Stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (2015 - nil). 0 0
Common stock, $0.001 par value 100,000,000 shares authorized (2015: 100,000,000), 54,615,642 issued and outstanding (2015: 54,615,642) 54,616 54,616
Additional Paid-In Capital 27,179,827 27,179,827
Deficiency (27,445,233) (26,593,207)
Accumulated other comprehensive loss (54,569) (46,739)
Total Stockholders' Equity (Deficiency) (265,359) 594,497
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) $ 1,232,619 $ 2,166,418